Late relapsing stage I nonseminoma

Journal of Clinical Oncology

Volumn 26, Issue 34, 2008, Pages 5647-5648

  Pezaro, Carmel J ^a   Mallesara, Girish ^b   Toner, Guy C ^a,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE;

ADULT; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LYMPH NODE DISSECTION; MALE; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TESTIS TUMOR; TREATMENT OUTCOME;

ADULT; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; TESTICULAR NEOPLASMS; TESTIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 57149120333     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.3417     Document Type: Article

References (12)

1. Oldenburg J, Martin JM, Fossa SD: Late relapses of germ cell malignancies: Incidence, management, and prognosis. J Clin Oncol 24:5503-5511, 2006
2. Vergouwe Y, Steyerberg EW, Eijkemans MJ, et al: Predictors of occult metastasis in clinical stage I nonseminoma: A systematic review. J Clin Oncol 21:4092-4099, 2003
3. Krege S, Beyer J, Souchon R, et al: European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG) - Part I. Eur Urol 53:478-496, 2008
4. Krege S, Beyer J, Souchon R, et al: European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol 53:497-513, 2008
5. Carver BS, Motzer RJ, Kondagunta GV, et al: Late relapse of testicular germ cell tumors. Urol Oncol 23:441-445, 2005
6. Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 13:1170-1176, 1995
7. Spermon JR, Roeleveld TA, van der Poel HG, et al: Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors. Urology 59:923-929, 2002
8. Huddart RA, Purkalne G: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT). Ann Oncol 16:i37-i39, 2005 (suppl 1)
9. Rustin GJ, Mead GM, Stenning SP, et al: Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Res Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25:1310-1315, 2007
10. van As NJ, Gilbert DC, Money-Kyrle J, et al: Evidence-based pragmatic guidelines for the follow-up of testicular cancer: Optimising the detection of relapse. Br J Cancer 98:1894-1902, 2008
11. National Comprehensive Cancer Network: The Testicular Cancer Clinical Practice Guidelines in Oncology (Version 2.2008). http://www.nccn.org/ professionals/physician_gls/PDF/testicular.pdf
12. Hain SF, O'Doherty MJ, Timothy AR, et al: Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83:863-869, 2000